Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
about
Lung cancer staging: clinical and radiologic perspectivesPrognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer.The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma.Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancerPredicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunitiesOncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial CancerUncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California.Outcome of platinum-based chemotherapy for non-small-cell lung cancer patients with pleural dissemination detected during surgery.The science behind the 7th edition Tumour, Node, Metastasis staging system for lung cancer.The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel?The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-small Cell Lung Cancer.Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.[Observation - An Favorable Option Forthoracic Dissemination Patients with Lung Adenocarcinoma or Squamous Carcinoma].
P2860
Q24600394-C40C348D-9597-41DA-B39E-DECE1B2AC318Q33571340-0D9BDE74-16F5-4A79-BCE3-338EAC7B57ADQ33613697-D86B6735-8986-45A3-81AB-669DA9FE0203Q35540726-BEFA9176-9A89-4C4C-80DD-9D5BB4E7C2BFQ35996028-C0E7D427-97AF-4742-80F8-C9FAD9AE8E14Q36016428-AD95D173-6A87-44FD-8DB3-A8ED8D0ADBFEQ36951322-21D68328-C180-4A88-8786-A2BF020A7700Q37393760-62079A6D-2AE6-413E-960B-BAD53CE64FC9Q37560778-876AED3D-D55D-4A08-A6AD-477B0ADB5A7CQ37944931-D4CBDE07-51CF-46B1-BC8E-966EFF79F891Q38555848-CEA46E6F-E746-4046-9317-3AFFD1FAAA2BQ38607262-E3538B19-3209-48D3-A740-8D42B887A807Q38684749-0CCC061B-AADF-4E1C-93CD-A230EC6F6FA2Q39693900-55852431-5C36-4DB1-9DC4-A4D92E82BBFFQ40313930-27C99E2F-4F03-4ECC-9B45-52440FEDA9CAQ55440983-D9D51176-B271-4D8F-941A-58B1200F6417
P2860
Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Validation study of the propos ...... he California Cancer Registry.
@ast
Validation study of the propos ...... he California Cancer Registry.
@en
type
label
Validation study of the propos ...... he California Cancer Registry.
@ast
Validation study of the propos ...... he California Cancer Registry.
@en
prefLabel
Validation study of the propos ...... he California Cancer Registry.
@ast
Validation study of the propos ...... he California Cancer Registry.
@en
P1476
Validation study of the propos ...... he California Cancer Registry.
@en
P2093
Jason A Zell
P304
P356
10.1097/JTO.0B013E318164545D
P577
2008-03-01T00:00:00Z